Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective

Jensen Yeung; Melinda J Gooderham; H Chih-Ho Hong; Charles Lynde; Vimal H Prajapati; Perla Lansang; Irina Turchin; Marni Wiseman; Carolyn Jack; Michele Ramien; Kerri Purdy; Parbeer Grewal

doi:10.1016/j.jaad.2023.01.053

Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective

J Am Acad Dermatol. 2023 Aug;89(2):372-375. doi: 10.1016/j.jaad.2023.01.053. Epub 2023 Apr 19.

Authors

Affiliations

¹ Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Probity Medical Research Inc, Waterloo, Ontario, Canada; Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada. Electronic address: jensen.yeung@utoronto.ca.
² Probity Medical Research Inc, Waterloo, Ontario, Canada; Queen's University, Kingston, Ontario, Canada; Skin Centre for Dermatology, Peterborough, Ontario, Canada.
³ Probity Medical Research Inc, Waterloo, Ontario, Canada; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada; Dr Chih-Ho Hong Medical Inc, Surrey, British Columbia, Canada; Probity Medical Research Inc, Surrey, British Columbia, Canada.
⁴ Probity Medical Research Inc, Waterloo, Ontario, Canada; Lynde Institute for Dermatology, Markham, Ontario, Canada.
⁵ Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Dermatology Research Institute, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Probity Medical Research Inc, Calgary, Alberta, Canada.
⁶ Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada; The Hospital for Sick Children, Toronto, Ontario, Canada.
⁷ Probity Medical Research Inc, Waterloo, Ontario, Canada; Brunswick Dermatology Center, Fredericton, New Brunswick, Canada; Dalhousie University, Halifax, Nova Scotia, Canada.
⁸ Probity Medical Research Inc, Waterloo, Ontario, Canada; SKiNWISE Dermatology, Winnipeg, Manitoba, Canada; Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
⁹ Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada; Infectious Diseases and Immunity in Global Health, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada; Innovaderm Research, Montreal, Quebec, Canada.
¹⁰ Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Pediatrics, Alberta Children's Hospital, Calgary, Alberta, Canada.
¹¹ Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
¹² Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada; Rejuvenation Dermatology, Edmonton, Alberta, Canada.

PMID: 37074241
DOI: 10.1016/j.jaad.2023.01.053

No abstract available

Keywords: atopic dermatitis; disease control; eczema; pruritus; treat-to-target.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antibodies, Monoclonal, Humanized
Canada
Dermatitis, Atopic* / diagnosis
Dermatitis, Atopic* / drug therapy
Eczema*
Humans
Pruritus
Severity of Illness Index
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized